Enjoy complimentary customisation on priority with our Enterprise License!
The rheumatoid arthritis diagnostic devices market share is expected to increase by USD 146.54 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.55%.
This rheumatoid arthritis diagnostic devices market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers rheumatoid arthritis diagnostic devices market segmentation by product (analyzers and consumables) and geography (North America, Europe, Asia, and Rest of World (ROW)). The rheumatoid arthritis diagnostic devices market report also offers information on several market vendors, including Abbott Laboratories, Antibodies Inc., Augurex Life Sciences Corp., Aviva Systems Biology Corp., Bio Rad Laboratories Inc., Danaher Corp., DNAlytics SA, Eurobio Scientific, F. Hoffmann La Roche Ltd., Myriad Genetics Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, Svar Life Science AB, Thermo Fisher Scientific Inc., and Werfenlife SA among others.
Download the Free Report Sample to Unlock the Rheumatoid Arthritis Diagnostic Devices Market Size for the Forecast Period and Other Important Statistics
The increasing number of rheumatoid arthritis cases is notably driving the rheumatoid arthritis diagnostic devices market growth, although factors such as the high costs associated with rheumatoid arthritis diagnosis may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the rheumatoid arthritis diagnostic devices industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Rheumatoid Arthritis Diagnostic Devices Market Driver
One of the rheumatoid arthritis diagnostic devices market is the increasing number of rheumatoid arthritis cases. The number of autoimmune disorders, such as rheumatoid arthritis, has grown across the world. Consequently, the demand for rheumatoid arthritis diagnostic devices is increasing. Rheumatoid arthritis is common in all age groups; however, this autoimmune disease is more common in the older population as the prevalence of rheumatoid arthritis increases with age. The increasing prevalence of rheumatoid arthritis has led to various countries worldwide conducting awareness programs. Such awareness programs can create awareness about the diagnosis procedures and treatment plans. In addition, the availability of reimbursement for rheumatoid arthritis in a few European countries, such as the UK and France, will boost the adoption of rheumatoid arthritis diagnostic devices. Similarly, the presence of public and private health insurance providers in various countries contributes to market growth.
Key Rheumatoid Arthritis Diagnostic Devices Market Trend
The growing number of business strategies is a rheumatoid arthritis diagnostic devices market trend that is expected to have a positive impact in the coming years. Vendors in various regions are adopting several business strategies such as distribution partnerships to increase their sales, which can help them to expand their business and strengthen their market position. The increasing demand for rheumatoid arthritis diagnostic devices is encouraging the leading vendors to expand their geographic reach, which can boost market growth. Business strategies can help companies that manufacture medical equipment to explore additional opportunities without incurring a considerable financial burden. The increasing number of partnerships, licensing agreements, and collaborations between vendors and distribution channel partners will expand the global presence of vendors and contribute to market growth during the forecast period.
Key Rheumatoid Arthritis Diagnostic Devices Market Challenge
The high costs associated with rheumatoid arthritis diagnosis will be a major challenge for the rheumatoid arthritis diagnostic devices market during the forecast period. The increasing prevalence of rheumatoid arthritis will spur the demand for rheumatoid arthritis diagnostic devices. However, the high cost of these devices prevents their wider adoption. For instance, the average cost of rheumatoid arthritis diagnostic analyzers is $8,000-$15,000, depending on the technology and its applications. The cost increases depending on the efficacy of the analyzer. Similarly, consumables that are used to detect rheumatoid arthritis, such as assays and test kits, play an important role in the early diagnosis of the disease by providing target biomarkers for accurate results. The use of these consumables can increase the cost burden on end-users, such as small and medium-sized diagnostic service providers that have to purchase consumables based on the number of tests performed. The high cost associated with the diagnosis of rheumatoid arthritis can impact the adoption of diagnostic devices, which can, in turn, have a negative impact on the adoption of diagnostic services.
This rheumatoid arthritis diagnostic devices market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global rheumatoid arthritis diagnostic devices market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the rheumatoid arthritis diagnostic devices market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the rheumatoid arthritis diagnostic devices market encompasses successful business strategies deployed by the key vendors. The rheumatoid arthritis diagnostic devices market is concentrated and the vendors are deploying growth strategies such as focusing not only on expanding their product ranges through distribution partnerships and collaborations to develop advanced technologies but also on the acquisition of smaller companies and business units to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The rheumatoid arthritis diagnostic devices market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the rheumatoid arthritis diagnostic devices market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request for a FREE sample now!
39% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for rheumatoid arthritis diagnostic devices in North America. Market growth in this region will be slower than the growth of the market in the European and Asian regions.
The increasing number of people with rheumatoid arthritis, the rising number of new product launches, the growing adoption of early diagnostic tests for rheumatoid arthritis, and the availability of public and private insurance for rheumatoid arthritis tests will facilitate the rheumatoid arthritis diagnostic devices market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The outbreak of COVID-19 led to the slow growth of the rheumatoid arthritis diagnostic devices market in 2020. Due to the implementation of stringent lockdowns, the manufacturing of these products came to a halt, which negatively impacted the production volume of rheumatoid arthritis diagnostic devices in North America, and, in turn, hindered the growth of the regional market in 2020. However, this situation is expected to stabilize during the forecast period, with the gradual containment of the pandemic, due to the lifting of lockdowns and the resumption of manufacturing of rheumatoid arthritis diagnostic devices in North America.
To gain further insights on the market contribution of various segments Request for a FREE sample
The rheumatoid arthritis diagnostic devices market share growth by the analyzers segment will be significant during the forecast period. Rheumatoid arthritis analyzers are costly as they can perform multiple functions. Such analyzers help to detect or to analyze specific proteins such as CCP antibodies and the rheumatoid factor. Vendors in the market are focusing on developing automated analyzers, which are highly advanced and can provide test results with better efficacy. These analyzers enable high-quality testing results, which, in turn, reduce the turnaround time and enhance productivity.
This report provides an accurate prediction of the contribution of all the segments to the growth of the rheumatoid arthritis diagnostic devices market size and actionable market insights on post COVID-19 impact on each segment.
Rheumatoid Arthritis Diagnostic Devices Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.55% |
Market growth 2022-2026 |
$ 146.54 million |
Market structure |
Concentrated |
YoY growth (%) |
5.25 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 39% |
Key consumer countries |
US, Canada, Germany, France, and Japan |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Abbott Laboratories, Antibodies Inc., Augurex Life Sciences Corp., Aviva Systems Biology Corp., Bio Rad Laboratories Inc., Danaher Corp., DNAlytics SA, Eurobio Scientific, F. Hoffmann La Roche Ltd., Myriad Genetics Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, Svar Life Science AB, Thermo Fisher Scientific Inc., and Werfenlife SA |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.